APA (7th ed.) Citation

Boll, L. M., Perera-Bel, J., Rodriguez-Vida, A., Arpí, O., Rovira, A., Juanpere, N., . . . Bellmunt, J. (2023). The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer. Scientific Reports, 13(1), 1. https://doi.org/10.1038/s41598-023-42495-2

Chicago Style (17th ed.) Citation

Boll, Lilian Marie, et al. "The Impact of Mutational Clonality in Predicting the Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer." Scientific Reports 13, no. 1 (2023): 1. https://doi.org/10.1038/s41598-023-42495-2.

MLA (9th ed.) Citation

Boll, Lilian Marie, et al. "The Impact of Mutational Clonality in Predicting the Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer." Scientific Reports, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1038/s41598-023-42495-2.